Literature DB >> 3640591

Antibiotic-resistant bacteria in surveillance stool cultures of patients with prolonged neutropenia.

J R Wingard, J Dick, P Charache, R Saral.   

Abstract

The value of stool surveillance for antibiotic-resistant gram-negative bacteria was analyzed in 86 neutropenic bone marrow transplant patients. Twice-weekly specimens were inoculated onto culture medium containing gentamicin plus carbenicillin. The recovered organisms were identified to the species level and tested for antibiotic susceptibility. Forty-eight resistant organisms were recovered from 35 patients. Thirteen isolates persistently colonized patients. Escherichia coli (29%) and Pseudomonas aeruginosa (19%) were the most frequently recovered organisms. Although most organisms were recovered while patients were on antibiotics, 15 isolates, including eight of nine resistant P. aeruginosa, were detected before antibiotics were initiated. The duration of antibiotic use was longer for patients persistently colonized than for those not colonized (P = 0.03). Of the 15 resistant organisms which caused infection, 12 were detected in the surveillance cultures. Infections by antibiotic-resistant organisms occurred more frequently in patients colonized than in those not colonized (P = 0.006) and more frequently in patients persistently colonized than in those colonized only once (P = 0.01). The absence of colonization or persistent colonization correlated well with the absence of infection (negative predictive values of 94 and 91%, respectively).

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3640591      PMCID: PMC180575          DOI: 10.1128/AAC.30.3.435

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Effect of prophylactic measures on the microbial flora of patients in protected environment units.

Authors:  G P Bodey; B Rosenbaum
Journal:  Medicine (Baltimore)       Date:  1974-05       Impact factor: 1.889

2.  Gastrointestinal "sterilization" in the treatment of patients with acute leukemia.

Authors:  H D Preisler; I M Goldstein; E S Henderson
Journal:  Cancer       Date:  1970-11       Impact factor: 6.860

3.  Protected environments and prophylactic antibiotics. A prospective controlled study of their utility in the therapy of acute leukemia.

Authors:  A S Levine; S E Siegel; A D Schreiber; J Hauser; H Preisler; I M Goldstein; F Seidler; R Simon; S Perry; J E Bennett; E S Henderson
Journal:  N Engl J Med       Date:  1973-03-08       Impact factor: 91.245

4.  Fluorescence polarization immunoassay. I. Monitoring aminoglycoside antibiotics in serum and plasma.

Authors:  M E Jolley; S D Stroupe; C H Wang; H N Panas; C L Keegan; R L Schmidt; K S Schwenzer
Journal:  Clin Chem       Date:  1981-07       Impact factor: 8.327

5.  Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

Authors:  D T Sleijfer; N H Mulder; H G de Vries-Hospers; V Fidler; H O Nieweg; D van der Waaij; H K van Saene
Journal:  Eur J Cancer       Date:  1980-06       Impact factor: 9.162

6.  Pseudomonas aeruginosa resistant to carbenicillin and gentamicin. Epidemiologic and clinical aspects in a cancer center.

Authors:  W H Greene; M Moody; S Schimpff; V M Young; P H Wiernik
Journal:  Ann Intern Med       Date:  1973-11       Impact factor: 25.391

7.  Microbiological monitoring of protected environment units. Effects of antibiotic prophylaxis and type of unit.

Authors:  G P Bodey; B Rosenbaum
Journal:  Eur J Cancer       Date:  1980-01       Impact factor: 9.162

8.  Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

Authors:  S C Schimpff; V M Young; W H Greene; G D Vermeulen; M R Moody; P H Wiernik
Journal:  Ann Intern Med       Date:  1972-11       Impact factor: 25.391

9.  Granulocytopenia in hospitalized patients: I. Prognostic factors and etiology of fever.

Authors:  M J Gurwith; J L Brunton; B A Lank; A R Ronald; G K Harding
Journal:  Am J Med       Date:  1978-01       Impact factor: 4.965

10.  Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.

Authors:  H G de Vries-Hospers; D T Sleijfer; N H Mulder; D van der Waaij; H O Neiweg; H K van Saene
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

View more
  12 in total

1.  Molecular epidemiological study of Pseudomonas aeruginosa isolates from patients with acute leukemia.

Authors:  W Kern; C Wolz; G Döring
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

2.  Gastrointestinal colonization with a cephalosporinase-producing bacteroides species preserves colonization resistance against vancomycin-resistant enterococcus and Clostridium difficile in cephalosporin-treated mice.

Authors:  Usha Stiefel; Michelle M Nerandzic; Michael J Pultz; Curtis J Donskey
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

3.  Prevention of bacterial infection in pediatric oncology: what do we know, what can we learn?

Authors:  Sarah Alexander; Michael Nieder; Danielle M Zerr; Brian T Fisher; Christopher C Dvorak; Lillian Sung
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

4.  Antibiotic treatment and intestinal colonization by Pseudomonas aeruginosa in cancer patients.

Authors:  A Andremont; B Marang; C Tancrède; D Baume; C Hill
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.

Authors:  J Kristie Johnson; Gwen L Robinson; Lisa L Pineles; Adebola O Ajao; LiCheng Zhao; Jennifer S Albrecht; Anthony D Harris; Kerri A Thom; Jon P Furuno
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia.

Authors:  Ryoko Yamasaki; Junya Kanda; Yu Akahoshi; Hirofumi Nakano; Tomotaka Ugai; Hidenori Wada; Koji Kawamura; Yuko Ishihara; Kana Sakamoto; Miki Sato; Masahiro Ashizawa; Tomohito Machishima; Kiriko Terasako-Saito; Shun-Ichi Kimura; Misato Kikuchi; Hideki Nakasone; Rie Yamazaki; Shinichi Kako; Junji Nishida; Yoshinobu Kanda
Journal:  Int J Hematol       Date:  2017-02-06       Impact factor: 2.490

7.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

Authors:  Diana Averbuch; Christina Orasch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

8.  Use of Shotgun Metagenome Sequencing To Detect Fecal Colonization with Multidrug-Resistant Bacteria in Children.

Authors:  Heidi Andersen; Natalia Connolly; Hansraj Bangar; Mary Staat; Joel Mortensen; Barbara Deburger; David B Haslam
Journal:  J Clin Microbiol       Date:  2016-04-27       Impact factor: 5.948

9.  Value of surveillance cultures in the management of neutropenic patients.

Authors:  M A Daw; P Munnelly; S R McCann; P A Daly; F R Falkiner; C T Keane
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-12       Impact factor: 3.267

10.  Gut microbiota profiling in hematopoietic stem cell transplant recipients: Towards personalized medicine.

Authors:  J S Gill; S P Singh; Sanjeevan Sharma; Ashwini Agarwal
Journal:  Med J Armed Forces India       Date:  2019-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.